Preliminary Anatomical and Neurodevelopmental Outcomes of Intravitreal Bevacizumab As Adjunctive Treatment for Retinopathy of Prematurity


Araz-Ersan B., Kir N., Tuncer S., Aydinoglu-Candan O., Yildiz-Inec D., Akdogan B., et al.

CURRENT EYE RESEARCH, cilt.40, ss.585-591, 2015 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 40 Konu: 6
  • Basım Tarihi: 2015
  • Doi Numarası: 10.3109/02713683.2014.941070
  • Dergi Adı: CURRENT EYE RESEARCH
  • Sayfa Sayısı: ss.585-591

Özet

Purpose: To evaluate the two-year follow-up of patients with type 1 retinopathy of prematurity (ROP) who received intravitreal bevacizumab (IVB) as adjunctive treatment.